Clinical Trial Update: N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating N-acetylcysteine for thrombolysis in acute ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Hospital, Caen | Conditions: Stroke, Ischemic | Phase 2 | Status: TERMINATED